T-cell response to adenovirus hexon and DNA-binding protein in mice

Gene Therapy

Volumn 11, Issue 9, 2004, Pages 791-796

  McKelvey, T ^a   Tang, A ^a   Bett, A J ^a   Casimiro, D R ^a   Chastain, M ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Adenovirus; Cell mediated immunity; DNA binding protein; ELISPOT; Hexon

Indexed keywords

ADENOVIRUS VECTOR; ALKALINE PHOSPHATASE; CD8 ANTIGEN; DNA BINDING PROTEIN; EPITOPE; GAMMA INTERFERON; PHOSPHATASE; STRUCTURAL PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE RELEASE; DOSE TIME EFFECT RELATION; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; ENZYME LINKED IMMUNOSPOT ASSAY; ENZYME RELEASE; EVIDENCE BASED MEDICINE; EXPOSURE; FEMALE; GENE DELETION; GENE IDENTIFICATION; GENETIC CODE; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNOREACTIVITY; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SEROTYPE; T LYMPHOCYTE; TIME; VIRAL GENE DELIVERY SYSTEM; VIRUS HEXON; WILD TYPE;

ADENOVIRIDAE; ADENOVIRUS E1 PROTEINS; ANIMALS; ANTIGENS, VIRAL; B-LYMPHOCYTES; CAPSID PROTEINS; CD8-POSITIVE T-LYMPHOCYTES; DNA-BINDING PROTEINS; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; FEMALE; GENETIC VECTORS; IMMUNITY, CELLULAR; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, SCID;

ADENOVIRIDAE;

EID: 2442715027     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3302232     Document Type: Article

References (29)

1. Yang Y, Li Q, Ertl HCJ, Wilson JM. Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses. J Virol 1995; 69: 2004-2015.
2. Yei S et al. Adenovirus-mediated gene transfer for cystic fibrosis: quantitative evaluation of repeated in vivo vector administration to the lung. Gene Therapy 1994; 1: 192-200.
3. Dai Y et al. Cellular and humoral immune responses to adenoviral vectors containing factor IX gene: tolerization of factor IX and vector antigens allows for long-term expression. Proc Natl Acad Sci USA 1995; 92: 1401-1405.
4. DeMatteo RP et al. Immunological barriers to hepatic adenoviral gene therapy for transplantation. Transplantation 1997; 63: 315-319.
5. Yang Y, Haecker S, Su Q, Wilson JM. Immunology of gene therapy with adenoviral vectors in mouse skeletal muscle. Hum Mol Gen 1996; 5: 1703-1712.
6. Tripathy SK, Black HB, Goldwasser E, Leiden JM. Immune responses to transgene-encoded proteins limit the stability of gene expression after injection of replication-defective adenovirus vectors. Nat Med 1996; 2: 545-550.
7. Gahery-Segard H et al. Immune response to recombinant capsid proteins of adenovirus in humans: antifiber and anti-penton base antibodies have a synergistic effect on neutralizing activity. J Virol 1998; 72: 2388-2397.
8. Chen P, Kovesdi I, Bruder JT. Effective repeat administration with adenovirus vectors to the muscle. Gene Therapy 2000; 7: 587-595.
9. Yang Y, Ertl HCJ, Wilson JM. MHC class I-restricted cytotoxic T-lymphocytes to viral antigens destroy hepatocytes in mice infected with E1-deleted recombinant adenoviruses. Immunity 1994; 1: 433-442.
10. Yang Y, Su Q, Wilson JM. Role of viral antigens in destructive cellular immune responses to adenovirus vector-transduced cells in mouse lungs. J Virol 1996; 70: 7209-7212.
11. Yang Y et al. Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy. Proc Natl Acad Sci USA 1994; 91: 4407-4411.
12. Kafri T et al. Cellular immune response to adenoviral vector infected cells does not require de novo viral gene expression: implications for gene therapy. Proc Natl Acad Sci USA 1998; 95: 11377-11382.
13. Jooss K, Ertl HCJ, Wilson J. Cytotoxic T-lymphocyte target proteins and their major histocampatibilty complex class I restriction in response to adenovirus vectors delivered to mouse liver. J Virol 1998; 72: 2945-2954.
14. Molinier-Frenkel V et al. Adenovirus hexon protein is a potent adjuvant for activation of a cellular immune response. J Virol 2002; 76: 127-135.
15. Olive M et al. The adenovirus capsid protein hexon contains a highly conserved human CD4+ T-cell epitope. Hum Gene Ther 2002; 13: 1167-1178.
16. Molinier-Frenkel V et al Immune response to recombinant adenovirus in humans: capsid proteins from viral input are targets for vector-specific cytotoxic T lymphocytes. J Virol 2000; 74 (16): 7678-7682.
17. Chirmule N et al. Role of E4 in eliciting CD4 T-cell and B-cell responses to adenovirus vectors delivered to murine and nonhuman primate lungs. J Virol 1998; 72: 6138-6145.
18. Lusky M et al. In vitro and in vivo biology of recombinant adenovirus vectors with E1, E1/E2A, or E1/E4 deleted. J Virol 1998; 72: 2022-2032.
19. Morsy M et al An adenoviral vector deleted for all viral coding sequences results in enhanced safety and extended expression of a leptin transgene. Appl Biol Sci 1998; 95: 7866-7871.
20. Ilan Y et al. Insertion of the adenoviral E3 region into a recombinant viral vector prevents antiviral humoral and cellular immune responses and permits long-term gene expression. Proc Natl Acad Sci USA 1997; 94: 2587-2592.
21. Mastrangeli A et al. Sero-switch adenovirus-mediated in vivo gene transfer: circumvention of anti-adenovirus humoral immune defenses against repeat adenovirus vector administration by changing the adenovirus serotype. Hum Gene Ther 1996; 7: 79-87.
22. Mack CA et al. Circumvention of anti-adenovirus neutralizing immunity by administration of an adenoviral vector of an alternate serotype. Hum Gene Ther 1997; 8: 99-109.
23. Qin L et al. Adenovirus-mediated gene transfer of viral interleukin-10 inhibits the immune response to both alloantigen and adenoviral antigen. Hum Gene Ther 1997; 8: 1365-1374.
24. Peng Y, Falck-Pedersen E, Elkon KB. Soluble CD8 attenuates cytotoxic T-cell responses against replication-defective adenovirus affording transprotection of transgene in vivo. J Immun 2000; 165: 1470-1478.
25. Jooss K, Yang Y, Wilson J. Cyclophosphamide diminishes inflammation and prolongs transgene expression following delivery of adenoviral vectors to mouse liver and lung. Hum Gene Ther 1996; 7: 1555-1566.
26. Fallaux FJ et al New helper cells and matched early region 1-deleted adenovirus vectors prevent generation of replication-competent adenoviruses. Hum Gene Ther 1998; 9: 1909-1917.
27. Berger J et al. Secreted placental alkaline phosphatase: a powerful new quantitative indicator of gene expression in eukaryotic cells. Gene 1988; 66: 1-10.
28. Chapman B, Thayer R, Vincent K, Haigwood N. Effect of intron A from human cytomegalovirus (Towne) immediate-early gene on heterologous expression in mammalian cells. Nucleic Acids Res 1991; 19: 3979-3986.
29. Klinman DM, Nutman TB. ELISPOT Assay to detect cytokine-secreting murine and human cells. In: Coligan JE et al (ed). Current Protocols in Immunology. John Wiley & Sons, Inc: New York, 1994; 1:pp 6.19.1-8.